Nevertheless, several other mechanisms and drugs are under investigation and there is continuous improvement of existing approaches as described above [128], which is important since Rac is upregulated in over 10% of cancer cases, remaining a valid potential target in tumorigenesis [140]. Here, AKT1 is linked to cancer.